Tailored Therapies for Cardiogenic Shock in Hypertrophic Cardiomyopathy: Navigating Emerging Strategies
Journal of Cardiovascular Development and Disease · 11.12.2024 · 11 (12) · 401
DOI: 10.3390/jcdd11120401 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 11.12.2024. Verfasst von George E Zakynthinos und 10 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Cardiology, "Sotiria" Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is a complex and heterogeneous cardiac disorder, often complicated by cardiogenic shock, a life-threatening condition marked by severe cardiac output failure. Managing cardiogenic shock in HCM patients presents unique challenges due to the distinct pathophysiology of the disease, which includes dynamic left ventricular outflow tract obstruction, diastolic dysfunction, and myocardial ischemia. This review discusses current and emerging therapeutic strategies tailored to address the complexities of HCM-associated cardiogenic shock and other diseases with similar pathophysiology that provoke left ventricular outflow tract obstruction. We explore the role of pharmacological interventions, including the use of vasopressors and inotropes, which are crucial in stabilizing hemodynamics but require careful selection to avoid exacerbating the outflow obstruction. Additionally, the review highlights advancements in mechanical circulatory support devices such as extracorporeal membrane oxygenation (ECMO) and left ventricular assist devices (LVADs), which have become vital in the acute management of cardiogenic shock. These devices provide temporary support and bridge patients to recovery, definitive therapy, or heart transplantation, which remains a critical option for those with end-stage disease. Furthermore, the review delves into the latest research and clinical trials that are refining these therapeutic approaches, ensuring they are optimized for HCM patients. The impact of these treatments on patient outcomes, including survival rates and quality of life, is also critically assessed. In conclusion, this review underscores the importance of a tailored therapeutic approach in managing cardiogenic shock in HCM patients, integrating pharmacological and mechanical support strategies to improve outcomes in this high-risk population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 3rd Department of Cardiology, "Sotiria" Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Critical Care Department, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41335 Larissa, Greece.
- Department of Cardiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece.
- Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: George E Zakynthinos, Ioannis Gialamas, Vasiliki Tsolaki, Panteleimon Pantelidis, Maria Ioanna Gounaridi, Andrew Xanthopoulos, Konstantinos Kalogeras, Evangelos Oikonomou
Zitieren
APA
Zakynthinos, G. E., Gialamas, I., Tsolaki, V., Pantelidis, P., Goliopoulou, A., Gounaridi, M. I., Tzima, I., Xanthopoulos, A., Kalogeras, K., Siasos, G., & Oikonomou, E. (2024). Tailored Therapies for Cardiogenic Shock in Hypertrophic Cardiomyopathy: Navigating Emerging Strategies. Journal of Cardiovascular Development and Disease, 11(12), 401. https://doi.org/10.3390/jcdd11120401
Vancouver
Zakynthinos GE, Gialamas I, Tsolaki V, Pantelidis P, Goliopoulou A, Gounaridi MI, et al. Tailored Therapies for Cardiogenic Shock in Hypertrophic Cardiomyopathy: Navigating Emerging Strategies. Journal of Cardiovascular Development and Disease. 2024;11(12):401. doi:10.3390/jcdd11120401
BibTeX
@article{Zakynthinos2024,
author = {Zakynthinos, George E and Gialamas, Ioannis and Tsolaki, Vasiliki and Pantelidis, Panteleimon and Goliopoulou, Athina and Gounaridi, Maria Ioanna and Tzima, Ioanna and Xanthopoulos, Andrew and Kalogeras, Konstantinos and Siasos, Gerasimos and Oikonomou, Evangelos},
title = {Tailored Therapies for Cardiogenic Shock in Hypertrophic Cardiomyopathy: Navigating Emerging Strategies},
journal = {Journal of Cardiovascular Development and Disease},
year = {2024},
volume = {11},
number = {12},
pages = {401},
doi = {10.3390/jcdd11120401}
}
EUVIMED